Loading clinical trials...
Loading clinical trials...
Aphasia is a disorder of spoken and written language, most commonly following a stroke. It is estimated that between 2.5 and 4 million Americans are living with aphasia today. A common problem in apha...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Albert Einstein Healthcare Network
Collaborators
NCT07036406 · Aphasia, Aphasia Following Cerebral Infarction, and more
NCT05653440 · Aphasia, Stroke
NCT04682223 · Aphasia, Stroke, and more
NCT06739967 · Primary Progressive Aphasia(PPA)
NCT04715399 · Frontotemporal Degeneration(FTD), Primary Progressive Aphasia(PPA), and more
Jefferson Moss Rehabilitation Research Institute
Elkins Park, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions